2Braun ankylo contro J,Brandt J,Listing J,et al.Treatment of active sing spondylitis with infliximab:a randomised lled multicentre trial [J ] .Lancet,2002,359 (9313) :1187-1193.
3van der Heijde D,Dijkmans B,Geusens P,et al.Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial ( ASSERT ) [J] .Arthritis Rheum,2005,52 ( 2 ) :582-591.
4Marzo-Ortega H,McGonagle D,Jarrett S,et al Inftiximab in combination with methotrexate in active ankylosing spondylitis: a clinical and imaging study[ J ].Ann Rheum Dis,2005,64 ( 11 ) :1568-1575.
5Gorman JD,Sack KE,Davis JC Jr.Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor [J] .N Engl J Med,2002,346 ( 18 ) :1349-1356.
6Bran& J,Khariouzov A,Listing J,et al.Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondy- lifts [ J ] .Arthritis Rheum,2003,48 ( 6 ) : 1667-1675.
7Davis JC Jr, van der Heijde D,Braun Let al. Recombinant human tumor necrosis factor receptor ( etanercept ) for treating ankylosing spondylitis:a randomized,controlled trial [J] .Arthritis Rheum,2003,48 ( 11 ) :3230-3236.
8Calin A,Dijkmans BA,Emery P,et al.Outcomes of a multicentre randomized clinical trial of etanercept to treat ankylosing spondylitis [ J ] .Ann Rheum Dis,2004,63 (12) :1594-1600.
9Hellgren K, Smedby spondylitis,psoriatic KE,Backlin C,et al.Ankylosing arthritis,and risk of malignant lymphoma:a cohort study based on nationwide prospectively recorded data from sweden [ J] Arthritis Rheumatol,2014,66 ( 5 ) :1282-1290.
10van der Heijde D,Zack D,Wajdula J,et al.Rates of serious infections,opportunistic infections,inflammatory bowel disease,and malignancies in subjects receivingetanercept vs. controls from clinical trials in ankylosing spondylitis: a pooled analysis [ J ] .Scand J Rheumatol, 2014,43 ( 1 ) :49-53.
